We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$308M
AUM Growth
-$109M
Cap. Flow
-$101M
Cap. Flow %
-32.88%
Top 10 Hldgs %
27.78%
Holding
155
New
31
Increased
75
Reduced
13
Closed
36

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.3M
2
DLTR icon
Dollar Tree
DLTR
+$5.02M
3
IMMR icon
Immersion
IMMR
+$4.97M
4
MCK icon
McKesson
MCK
+$4.21M
5
BPOP icon
Popular Inc
BPOP
+$3.58M

Sector Composition

Rank Sector Weight
1 Financials 14.96%
2 Consumer Discretionary 13.29%
3 Materials 11.69%
4 Industrials 11.21%
5 Healthcare 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDR icon
76
Schneider National
SNDR
$6.18B
$1.23M 0.4%
+54,219
New +$1.2M
KNX icon
77
Knight Transportation
KNX
$11.2B
$1.21M 0.39%
+23,673
New +$1.19M
CPS icon
78
Cooper-Standard Automotive
CPS
$514M
$1.19M 0.39%
54,323
+18,495
+52% +$444K
XPOF icon
79
Xponential Fitness
XPOF
$208M
$1.19M 0.38%
+93,372
New +$1.08M
CCEC
80
Capital Clean Energy Carriers
CCEC
$1.35B
$1.18M 0.38%
90,355
+9,868
+12% +$121K
RMR icon
81
The RMR Group
RMR
$332M
$1.16M 0.37%
34,538
-38,348
-53% -$1.46M
JOAN
82
DELISTED
JOANN, Inc. Common Stock
JOAN
$1.15M 0.37%
+102,752
New +$1.42M
LAZ icon
83
Lazard
LAZ
$4.2B
$1.13M 0.37%
24,767
-46,928
-65% -$2.19M
PMD
84
DELISTED
Psychemedics Corporation
PMD
$1.06M 0.35%
125,315
+13,661
+12% +$100K
UBER icon
85
Uber
UBER
$159B
$1.04M 0.34%
+23,282
New +$1.02M
VTOL icon
86
Bristow Group
VTOL
$1.37B
$1.02M 0.33%
32,099
+1,013
+3% +$29.6K
AGS
87
DELISTED
PlayAGS
AGS
$995K 0.32%
+126,245
New +$1M
SRTS icon
88
Sensus Healthcare
SRTS
$50.4M
$985K 0.32%
273,342
+5,442
+2% +$19.9K
UFI icon
89
UNIFI
UFI
$130M
$948K 0.31%
+43,226
New +$983K
FL
90
DELISTED
Foot Locker
FL
$938K 0.3%
20,524
+2,107
+11% +$117K
WEYS icon
91
Weyco Group
WEYS
$445M
$873K 0.28%
38,536
+6,965
+22% +$160K
FONR
92
DELISTED
Fonar
FONR
$843K 0.27%
54,539
+38,815
+247% +$658K
LSEA
93
DELISTED
Landsea Homes
LSEA
$813K 0.26%
93,861
+92,791
+8,672% +$796K
BWA icon
94
BorgWarner
BWA
$14.2B
$773K 0.25%
20,331
+2,136
+12% +$84.9K
PARA
95
DELISTED
Paramount Global Class B
PARA
$741K 0.24%
18,772
+2,029
+12% +$82.7K
SABR icon
96
Sabre
SABR
$831M
$741K 0.24%
+62,561
New +$709K
HYRE
97
DELISTED
HyreCar Inc. Common Stock
HYRE
$645K 0.21%
75,864
-77,395
-50% -$1.06M
LZB icon
98
La-Z-Boy
LZB
$1.67B
$602K 0.2%
+18,680
New +$644K
QCOM icon
99
Qualcomm
QCOM
$172B
$602K 0.2%
+4,666
New +$662K
POWL icon
100
Powell Industries
POWL
$7.57B
$587K 0.19%
+71,658
New +$644K

Similar funds

Invenomic Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Invenomic Capital Management held 155 positions worth $308M, down 26% from $418M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Invenomic Capital Management withdrew a net $101M in Q3 2021, closing 36 positions and reducing 13 holdings. Its most notable exit was Lockheed Martin, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.1% a quarter earlier, followed by Consumer Discretionary and Materials.

Against the trend, Invenomic Capital Management opened a new position in Alibaba worth $4.31M.

  • Invenomic Capital Management's largest Q3 2021 buy was Alibaba: 29,138 shares worth $4.31M.
  • Invenomic Capital Management added most to Immersion in Q3 2021, an estimated $4.97M increase.
  • Invenomic Capital Management's biggest Q3 2021 reduction was Teck Resources, cutting an estimated $3.41M.
  • Invenomic Capital Management fully exited Lockheed Martin in Q3 2021, selling an estimated $3.38M.
  • Invenomic Capital Management's ten largest holdings make up 28% of its $308M portfolio in Q3 2021.
  • Invenomic Capital Management opened 31 new positions and closed 36 in Q3 2021.
  • Invenomic Capital Management's portfolio value fell 26% quarter-over-quarter to $308M.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.